Health Economics and Policy, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Goteborg, Sweden.
University Health Care Research Center, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Health Econ. 2022 Sep;31(9):1862-1877. doi: 10.1002/hec.4552. Epub 2022 Jun 16.
There is substantial variation in drug spending across regions in Sweden, which can be justified if caused by differences in health need, but an indication of inefficiencies if primarily caused by differences in place-specific supply-side factors. This paper aims to estimate the relative effect of individual demand-side factors and place-specific supply-side factors as drivers of geographical variation in drug spending in Sweden. We use individual-level register data on purchases of prescription drugs matched with demographic and socioeconomic data of a random sample of about 900,000 individuals over 2007-2016. The primary empirical approach is a two-way fixed effect model and an event study where we identify demand- and supply-side effects based on how regional and local migrants change drug spending when moving across regional and municipal borders. As an alternative approach in robustness checks, we also use a decomposition analysis. The results show that the place-specific supply-side effect accounts for only about 5%-10% of variation in drug spending and remaining variation is due to individual demand-side effects. These results imply that health policies to reduce regional variation in drug spending would have limited impact if targeted at place-specific characteristics.
瑞典各地区的药品支出存在大量差异,如果这种差异是由健康需求的不同引起的,则可以说是合理的,但如果主要是由特定地点的供应方因素的不同引起的,则表明效率低下。本文旨在估计个别需求方因素和特定地点供应方因素作为瑞典药品支出地域差异驱动因素的相对影响。我们使用 2007-2016 年期间购买处方药的个人登记数据,并与大约 90 万人的人口统计和社会经济数据相匹配。主要的实证方法是双向固定效应模型和事件研究,我们根据区域和地方移民在跨越区域和市政边界时如何改变药品支出,来确定需求方和供应方的影响。作为稳健性检验的替代方法,我们还使用了分解分析。结果表明,特定地点的供应方效应仅占药品支出变化的 5%-10%左右,其余变化归因于个人需求方效应。这些结果表明,如果针对特定地点的特点制定减少药品支出地区差异的卫生政策,其影响将有限。